Related Experiment Videos

Alzheimer II astrocytosis following methionine sulfoximine

Archives of Neurology
|February 1, 1975
PubMed

Insights

Methionine sulfoximine (MSO) induces Alzheimer II astrocytes in rats, indicating astrocyte-specific metabolic changes. This suggests ammonia may mediate MSO toxicity and contribute to seizure development.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Toxicology

Background:

  • Alzheimer II astrocytes are linked to hyperammonemic conditions.
  • Methionine sulfoximine (MSO) is a neurotoxic agent.
  • Astrocytes play crucial roles in brain metabolism and function.

Purpose of the Study:

  • To investigate the early cellular changes in the brain following methionine sulfoximine (MSO) administration.
  • To determine the primary cell type affected by MSO toxicity.
  • To explore the potential role of ammonia in MSO-induced neurotoxicity and seizures.

Main Methods:

  • Light microscopic examination of adult rat brain tissue.
  • Administration of methionine sulfoximine (MSO) to induce a preictal state.
  • Morphological analysis focusing on astrocyte changes in gray matter.

Main Results:

  • The primary observation was the development of Alzheimer II astrocytes in the gray matter.
  • These changes suggest that the metabolic abnormality induced by MSO is initially localized to astrocytes.
  • The findings support a potential link between MSO toxicity, ammonia, and astrocyte dysfunction.

Conclusions:

  • MSO-induced neurotoxicity appears to initially affect astrocytes.
  • Ammonia may play a significant role in the toxic effects of MSO.
  • Astrocytes might be involved in the mechanism underlying MSO-induced seizures.

Related Concept Videos